Literature DB >> 25062053

Molecular structure, FT-IR, NBO, HOMO and LUMO, MEP and first order hyperpolarizability of (2E)-1-(2,4-Dichlorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one by HF and density functional methods.

Y Sheena Mary1, C Yohannan Panicker2, P L Anto3, M Sapnakumari4, B Narayana4, B K Sarojini5.   

Abstract

(2E)-1-(2,4-Dichlorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one is synthesized by using 2,4-dichloroacetophenone and 3,4,5-trimethoxybenzaldehyde in ethanol. The structure of the compound was confirmed by IR and single crystal X-ray diffraction studies. FT-IR spectrum of (2E)-1-(2,4-dichloro-phenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one was recorded and analyzed. The crystal structure is also described. The vibrational wavenumbers were computed using HF and DFT methods and are assigned with the help of potential energy distribution method. The first hyperpolarizability and infrared intensities are also reported. The geometrical parameters of the title compound obtained from XRD studies are in agreement with the calculated (DFT) values. The stability of the molecule arising from hyper-conjugative interaction and charge delocalization has been analyzed using NBO analysis. The HOMO and LUMO analysis are used to determine the charge transfer within the molecule. MEP was performed by the DFT method. From the MEP map of the title molecule, negative region is mainly localized over the electronegative oxygen atoms, in the carbonyl group and the oxygen atom O4 of the methoxy group and the maximum positive region is localized on the phenyl rings.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chlorophenyl; DFT; FT-IR; PED; Trimethoxy

Mesh:

Substances:

Year:  2014        PMID: 25062053     DOI: 10.1016/j.saa.2014.06.140

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  1 in total

1.  DFT and molecular docking investigations of oxicam derivatives.

Authors:  Y Shyma Mary; Y Sheena Mary; K S Resmi; Renjith Thomas
Journal:  Heliyon       Date:  2019-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.